Biofilm Production in Intensive Care Units: Challenges and Implications

Ferdiye Taner1,2, Buket Baddal1,2, Liana Theodoridis3

  • 1Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, 99138 Nicosia, Cyprus.

PubMed

Insights

Intensive care units (ICUs) are hotspots for multidrug-resistant bacteria and healthcare-associated infections. This review explores how ICU environments promote biofilm formation, aiding pathogen persistence and antibiotic resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Intensive care units (ICUs) are high-risk environments for infections, particularly those caused by multidrug-resistant bacteria.
  • Healthcare-associated infections (HAIs) are prevalent in ICUs despite ongoing efforts in monitoring and infection control.
  • Biofilm formation by pathogens is a significant challenge in ICUs, contributing to persistent infections and antimicrobial tolerance.

Purpose of the Study:

  • To review the factors within the ICU environment that contribute to and enhance biofilm production by pathogens.
  • To highlight the need for further molecular research into biofilm regulation and pathogen adaptation in ICUs.
  • To explore the relationship between biofilm production, antibiotic resistance, and ICU environmental cues.

Main Methods:

  • Comprehensive literature review of studies on microbial diversity, pathogen spread, and infection control in ICUs.
  • Analysis of factors influencing biofilm formation and persistence in the ICU setting.
  • Examination of the interplay between environmental cues, biofilm production, and antimicrobial resistance.

Main Results:

  • ICU environments harbor microbial diversity that persists despite antibiotic treatments.
  • Biofilm-producing pathogens pose a significant threat, with their formation being a persistent challenge in ICUs.
  • Understanding the ICU's role in promoting biofilm production and antibiotic resistance is crucial.

Conclusions:

  • ICU environments play a critical role in fostering biofilm production and the spread of antibiotic-resistant pathogens.
  • Additional molecular studies are needed to elucidate the mechanisms of biofilm regulation and pathogen adaptation in ICUs.
  • Targeting biofilm formation within the ICU context may be a key strategy to control persistent infections and reduce antimicrobial resistance.